Hyperuricemia as a Predictor of Poor Fetal Outcome in Pre-Eclamptic Women by Khaleeq, Aneela




Hyperuricemia as a Predictor of Poor Fetal Outcome in Pre-
Eclamptic Women 
 
AneelaKhaleeq*, Khadija Waheed*, Sara Ejaz*, Ahmad Kamal** 
*Department of Gynaecology/Obstetrics, King Edward Medical College, Lahore;**Department of Surgery , King Edward 
Medical College, Lahore. 
 
Abstract 
Background:To evaluate the relation between 
raised serum uric acid level and fetal outcome. 
Methods:This Cohort study was conducted at 
Department of Obstetrics and Gynaecology, Services 
Hospital, Lahore, to compare the risk of poor fetal 
outcome in hyperuricemic and normouricemic pre-
eclamptic patients. A total of 300 patients with the 
diagnosis of pre-eclampsia were included in the study 
and serum uric acid levels were obtained in all the 
patients. They were divided into two groups: Group 
A: Pre-eclamptic Normouricemic; Group B: Pre-
eclamptic Hyperuricemic. All patients were followed 
after delivery for fetal outcome and results were 
compared in both groups. 
Results: The mean maternal age was 28.60 ± 
3.308 years. The mean gestational age was 36.85 ± 0.59 
weeks. The mean uric acid level of the patients at 
presentation was 5.067 ± 1.74 mg/dl. The mean uric 
acid level in group A was 3.64 ± 0.73 mg/dl and in 
group B was 7.98 ± 0.85 mg/dl. In group A, 9.3% 
newborns were found small-for-gestational-age (SGA), 
whereas in Group B, 23.3% newborns were found 
having SGA. The relative risk was calculated for 
development of SGA in hyperuricemia and was found 
significant (RR=2.5; 95% CI: 1.40- 4.45). 
Conclusion: Serum uric acid level measurement is 
a useful and inexpensive marker for predicting pre-
eclampsia and fetal growth retardation in women 
presenting with gestational hypertension.  
Key Words:  Hyperuricemia, Pre-eclampsia, Fetal 
outcome 
Introduction 
Gestational hypertension is a medical disorder 
worldwide that complicates approximately 12-22% of 
the pregnancies.1  Pre-eclampsia is one of the subtypes 
of gestational hypertension, which is defined as the 
development of hypertension, proteinuria, or both 
after 20 weeks in a woman with previously normal 
blood pressure. Elevated uric acid is a component of 
pre-eclampsia syndrome that was recognized many 
years ago. Not only the hypertensive disorders in 
pregnancy are linked with elevated serum uric acid, 
but also the essential hypertension is also associated 
with the abnormalities in the levels of serum uric acid 
and lipid profile.2 The association of pre-eclampsia 
with gestational diabetes has also been well 
established in many trials.3 
Interpretation of uric acid level requires the exact 
knowledge of the duration of gestation, as its levels in 
normal pregnancy increases with the increasing 
gestation, i.e. 2-4.2 mg/dl, 2.4-4.9 mg/dl and 3.1-6.3 
mg/dl in 1st, 2nd and 3rd trimester of pregnancy 
respectively.4 Women with gestational hypertension 
and hyperuricemia have evidence of endothelial 
dysfunction and deliver growth-retarded babies.5 In 
women with gestational hypertension, hyperuricemia 
(>5.5 mg/dl) was associated with smaller birth weight 
centiles and increased risk of small-for-gestational-age 
(SGA) (6).According to a study, the prevalence of SGA 
in hyperuricemic pre-eclamptic women was 23.9% as 
compared to 12.3% for normouricemic pre-eclamptics, 
with RR[(95% CI)]: 2.0 (0.8-4.8).6  
 
Patients  and Methods 
It was a cohort study conducted at Department of 
Gynaecology and Obstetrics Unit-III, Services 
Hospital, Lahore over a period of one year from 
January 2014 to December, 2014. In this study, Pre-
eclampsia was defined as the development of 
hypertension (diastolic blood pressure > 90mm of Hg 
or systolic blood pressure > 140mm of Hg), proteinuria 
(presence of 300mg/dl or more protein in 24 hour 
urine specimen which correlates with a finding of +1 
of greater), or both, after 20 weeks of gestation in 
women with previously normal blood pressure. 
Hyperuricemia was defined as serum uric acid level 
more than 5.5mg/dl.The cut-off value of 5.5 mg/dL 
was decided by the authors because in most of the 
previous studies normal range for pregnant females is 
considered as >5.2-5.5 mg/dl.7Poor fetal outcome was 
measured in terms of fetus with SGA. Pre-eclamptic 
patients with all the gravida, between 25-35 years of 
age were included in the study. Patients with multiple 
gestations were excluded from the study as the 
incidence of SGA is reportedly high in multiple 
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pregnancies. Also patients with other co-existing 
medical disorders like maternal diabetes, renal, 
respiratory and hepatic dysfunction and placental 
abruption were excluded. A sample size of total 300 
patients with 150 being in each group was calculated, 
with 10% margin of error, 80% power of study, taking 
expected %age of SGA i.e. 23.9% in hyperuricemia and 
12.3% in normouricemia.6 
The pre-eclamptic patients were divided into 
normouricemic (Group-A) and hyperuricemic (Group-
B) groups after getting serum uric acid levels. A 
detailed history was taken and gestational age was 
calculated from the last menstrual period and dating 
scan. Fetal monitoring was done by maintaining SGA 
chart and ultrasonography.Patients were kept in 
follow up and baby was delivered according to 
gynaecological merits. Fetal weight was recorded at 
birth.Serum uric acid levels were done 
spectrophotometrically . 
Summaries were presented qualitatively in frequencies 
and percentages in both hyperuricemic and 
normouricemic groups. Quantitative summaries of 
age, gestational age, and baby weight were presented 
in terms of mean and standard deviation.Relative risk 
(RR) was calculated to see any association between 
hyperuricemic and small-for-gestational-age. RR>2 
was considered as significant. 
 
Results 
A total of 300 patients were included in the study. The 
two groups were comparable in terms of demographic 
details. The uric acid level in group A ranged from 2.7 
to 5.3 mg/dl and mean value was found to be 3.64 + 
0.73 mg/dl while in group B it ranged from 5.9 to 9.9 
mg/dl and mean value was found to be 7.98 ± 0.85 
mg/dl (Table 1) 
 
Table 1: Demographics of patients  
in both groups 
 Group A 
 
Group B 




Gestational Age (weeks) 






Uric Acid (mg/dl) 3.64+0.73 7.98 ± 0.85 
 
The birth weight of the newborns in both groups was 
also almost comparable, being 3.18 ± 0.44 Kg in group 
A while in group B, it was 2.91 ± 0.51 Kg. However 
there was difference in SGA newborns in both groups. 
In Group A 14 of 150 newborns (9.3%) were found 
SGA, whereas in Group B 35 of 150 newborns (23.3%) 
were found having SGA (Table 2). The relative risk 
was calculated for development of small for 
gestational age (SGA)  in hyperuricemia and was 
found significant (RR=2.5; 95% CI: 1.40- 4.45). It was 
found more than 2 and was significant. 
 
Table 2: Comparison of birth weight  
and SGA in both groups 
 Group A Group B 
Birth weight of Newborn 
(Kg) 
3.18 ± 0.44 2.91 ± 0.51 








Pre-eclampsia is a type of hypertension which is 
unique and confined to pregnancy. It is a common 
problem and occurs among 3-10% of nulliparous 
women during pregnancy. It is globally prevalent and 
contributes as a major cause to morbidity and 
mortality during pregnancy.8 It is a multi-system 
disorder and mainly involves kidneys. Due to 
endothelial damage in the kidneys, it causes 
proteinuria, hypertension and derangement of renal 
function.6 Studies reveal equal prevalence of 
preeclampsia among nulliparous and multiparous 
women.9-11 Whenever defining pre-eclampsia, 
hyperuricemia is not a commonly used criteria, but 
many studies have suggested that hyperuricemia 
during preganancy suggests gestational hypertension 
and can lead to an untoward outcome. 12,13  
Pre-eclampsia is a known cause of low birth weight 
and premature birth. The hyperuricemic group was 
found with a mean birth weight of 2.91 ± 0.51 Kg, 
lower than Group A in which mean birth weight was 
3.18 ± 0.44. Our results are comparable with such a 
study carried out in Dhaka, which showed a mean 
birth weight of 2.31 ± 0.71 Kg in pre-eclamptic women 
with hyperuricemia.14 
A rising serum uric acid is now recognized as an early 
feature of pre-eclampsia and its measurement greatly 
increases the diagnostic accuracy of pre-eclampsia.15,16 
The level of uric acid above 4.5 mg/dl is indicative of 
pre-eclamptic process and in such cases, the patients 
deserve careful and close clinical follow up.Increasing 
higher concentration of uric acid i.e. 5.7 mg/dl, 6.3 
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mg/dl, and 6.7 mg/dl was observed in pregnancy 
with chronic hypertension and pre-eclampsia.14 Serum 
uric acid could be used as a sensitive indicator of 
severity of pre-eclampsia.17 Lim KH found that the 
concentration of serum uric acid also correlated well 
with severity of the glomerular lesion.16 D'Anna R and 
colleagues concluded that the level of serum uric acid 
appears to be a sensitive index of the severity of pre-
eclampsia.18 
The frequency of SGA in our study was seen in 47 
newborns. Among all these 23.33% were from the 
hyperuricemic pre-eclamptic group. In a similar study 
there were 28% newborns found SGA in pre-eclamptic 
women with a mean serum uric acid level more than 
6.4 mg/dl. In that study, no newborn was found SGA 
in pre-eclamptic women who were with a mean serum 
uric acid levels of 5.6 ± 0.3 mg/dl at delivery.13 
However, in our study SGA was noted in 9 newborns 
in pre-eclamptic normouricemic group. 
High uric acid levels with pre-eclampsia during 
pregnancy leads to a spectrum of maternal and fetal 
outcomes.19 According to Parrish M and colleagues, 
adverse maternal outcomes occurred in 15.3% of 258 
patients in their cohort trial. The positive likelihood 
ratio (LR) for adverse maternal outcome was found 5.3 
with Uric acid levels ≥ 76.3 μmol/l. Also adverse 
perinatal outcomes occurred in 45.2% of births.20 In 
another study, it was found that hyperuricemic pre-
eclamptic mothers were associated with higher 
probability of delivery by caesarean section (33% 
versus 12%; p = 0.007).21In a study conducted on 
Japanese normotensive pregnant women, Akahori et 
al. documented that hyperuricemia in the third 
trimester of pregnancy is an independent risk factor 
for SGA delivery.22 In our study the relative risk for 
the development of SGA with hyperuricemia was 
calculated and found 2.2. It means that the pre-
eclamptic hyperuricemic patients are 2.2 times as 
likely as normouricemic pre-eclamptic to develop 
SGA. It was more than 2 and statistically significant 
making present study reliable in commenting about 
the association between hyperuricemia and SGA. 
Conclusion 
Serum uric acid level measurements are a useful and 
inexpensive marker for predicting pre-eclampsia and 
fetal growth retardation in women presenting with 
gestational hypertension.  
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